These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 2390486

  • 1. The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line.
    Meijer C, Mulder NH, Hospers GA, Uges DR, de Vries EG.
    Br J Cancer; 1990 Jul; 62(1):72-7. PubMed ID: 2390486
    [Abstract] [Full Text] [Related]

  • 2. Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds.
    Meijer C, Mulder NH, Timmer-Bosscha H, Sluiter WJ, Meersma GJ, de Vries EG.
    Cancer Res; 1992 Dec 15; 52(24):6885-9. PubMed ID: 1458477
    [Abstract] [Full Text] [Related]

  • 3. The formation and removal of cisplatin (CDDP) induced DNA adducts in a CDDP sensitive and resistant human small cell lung carcinoma (HSCLC) cell line.
    Hospers GA, de Vries EG, Mulder NH.
    Br J Cancer; 1990 Jan 15; 61(1):79-82. PubMed ID: 2153398
    [Abstract] [Full Text] [Related]

  • 4. Characterization of a human small cell lung carcinoma cell line with acquired resistance to cis-diamminedichloroplatinum(II) in vitro.
    Hospers GA, Mulder NH, de Jong B, de Ley L, Uges DR, Fichtinger-Schepman AM, Scheper RJ, de Vries EG.
    Cancer Res; 1988 Dec 01; 48(23):6803-7. PubMed ID: 2846161
    [Abstract] [Full Text] [Related]

  • 5. A study of human small-cell lung carcinoma (hSCLC) cell lines with different sensitivities to detect relevant mechanisms of cisplatin (CDDP) resistance.
    Hospers GA, Meijer C, de Leij L, Uges DR, Mulder NH, de Vries EG.
    Int J Cancer; 1990 Jul 15; 46(1):138-44. PubMed ID: 2163989
    [Abstract] [Full Text] [Related]

  • 6. Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells.
    Lai SL, Hwang J, Perng RP, Whang-Peng J.
    Oncol Res; 1995 Jul 15; 7(1):31-8. PubMed ID: 7549042
    [Abstract] [Full Text] [Related]

  • 7. JM216-, JM118-, and cisplatin-induced cytotoxicity in relation to platinum-DNA adduct formation, glutathione levels and p53 status in human tumour cell lines with different sensitivities to cisplatin.
    Fokkema E, Groen HJ, Helder MN, de Vries EG, Meijer C.
    Biochem Pharmacol; 2002 Jun 01; 63(11):1989-96. PubMed ID: 12093475
    [Abstract] [Full Text] [Related]

  • 8. Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell lines.
    Mistry P, Loh SY, Kelland LR, Harrap KR.
    Int J Cancer; 1993 Nov 11; 55(5):848-56. PubMed ID: 8244583
    [Abstract] [Full Text] [Related]

  • 9. Mechanisms associated with the expression of cisplatin resistance in a human ovarian tumor cell line following exposure to fractionated X-irradiation in vitro.
    Dempke WC, Shellard SA, Hosking LK, Fichtinger-Schepman AM, Hill BT.
    Carcinogenesis; 1992 Jul 11; 13(7):1209-15. PubMed ID: 1638688
    [Abstract] [Full Text] [Related]

  • 10. [Potentiation of cisplatin sensitivity of cisplatin-resistant human ovarian cancer cell lines by L-buthionine-S,R-sulfoximine].
    Kudoh K, Kita T, Hirata J, Ishii K, Hiramatsu H, Kikuchi Y, Nagata I.
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Jun 11; 46(6):525-32. PubMed ID: 8040625
    [Abstract] [Full Text] [Related]

  • 11. Circumvention of drug resistance in cisplatin-resistant sublines of the human squamous carcinoma cell line HLac 79 in vitro and in vivo.
    Bier H.
    Acta Otolaryngol; 1991 Jun 11; 111(4):797-806. PubMed ID: 1950544
    [Abstract] [Full Text] [Related]

  • 12. Effect of novobiocin on cisplatin cytotoxicity and DNA interstrand cross-link formation in a cisplatin-resistant, small-cell lung carcinoma cell line.
    de Jong S, Timmer-Bosscha H, de Vries EG, Mulder NH.
    Int J Cancer; 1993 Jan 02; 53(1):110-7. PubMed ID: 8380054
    [Abstract] [Full Text] [Related]

  • 13. Influence of docosahexaenoic acid on cisplatin resistance in a human small cell lung carcinoma cell line.
    Timmer-Bosscha H, Hospers GA, Meijer C, Mulder NH, Muskiet FA, Martini IA, Uges DR, de Vries EG.
    J Natl Cancer Inst; 1989 Jul 19; 81(14):1069-75. PubMed ID: 2544740
    [Abstract] [Full Text] [Related]

  • 14. Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein.
    Versantvoort CH, Broxterman HJ, Bagrij T, Scheper RJ, Twentyman PR.
    Br J Cancer; 1995 Jul 19; 72(1):82-9. PubMed ID: 7599070
    [Abstract] [Full Text] [Related]

  • 15. Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines.
    Groen HJ, Sleijfer S, Meijer C, Kampinga HH, Konings AW, De Vries EG, Mulder NH.
    Br J Cancer; 1995 Dec 19; 72(6):1406-11. PubMed ID: 8519652
    [Abstract] [Full Text] [Related]

  • 16. Schedule-dependent reversion of acquired cisplatin resistance by 5-fluorouracil in a newly established cisplatin-resistant HST-1 human squamous carcinoma cell line.
    Esaki T, Nakano S, Masumoto N, Fujishima H, Niho Y.
    Int J Cancer; 1996 Feb 08; 65(4):479-84. PubMed ID: 8621231
    [Abstract] [Full Text] [Related]

  • 17. Schedule dependence of buthionine sulfoximine in reversing resistance to cisplatin.
    Robichaud NJ, Fram RJ.
    Chem Biol Interact; 1990 Feb 08; 76(3):333-42. PubMed ID: 2225234
    [Abstract] [Full Text] [Related]

  • 18. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
    Ali-Osman F, Antoun G, Wang H, Rajagopal S, Gagucas E.
    Mol Pharmacol; 1996 Jun 08; 49(6):1012-20. PubMed ID: 8649339
    [Abstract] [Full Text] [Related]

  • 19. Mechanism of cross-resistance to cisplatin in a mitomycin C-resistant human bladder cancer cell line.
    Singh SV, Xu BH, Jani JP, Emerson EO, Backes MG, Rihn C, Scalamogna D, Stemmler N, Specht S, Blanock K.
    Int J Cancer; 1995 May 04; 61(3):431-6. PubMed ID: 7729958
    [Abstract] [Full Text] [Related]

  • 20. Anomalous relationship between cisplatin sensitivity and the formation and removal of platinum-DNA adducts in two human ovarian carcinoma cell lines in vitro.
    Shellard SA, Hosking LK, Hill BT.
    Cancer Res; 1991 Sep 01; 51(17):4557-64. PubMed ID: 1873800
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.